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Background: Evidence from clinical practice and the extant literature suggests that post-operative pain assessment
and treatment is often suboptimal. Poor pain management is likely to persist until pain management practices
become consistent with guidelines developed from the best available scientific evidence. This work will address the
priority in healthcare of improving the quality of pain management by standardising evidence-based care processes
through the incorporation of an algorithm derived from best evidence into clinical practice. In this paper, the
methodology for the creation and implementation of such an algorithm that will focus, in the first instance, on
patients who have undergone total hip or knee replacement is described.
Methods: In partnership with clinicians, and based on best available evidence, the aim of the Management
Algorithm for Post-operative Pain (MAPP) project is to develop, implement, and evaluate an algorithm designed to
support pain management decision-making for patients after orthopaedic surgery. The algorithm will provide
guidance for the prescription and administration of multimodal analgesics in the post-operative period, and the
treatment of breakthrough pain. The MAPP project is a multisite study with one coordinating hospital and two
supporting (rollout) hospitals. The design of this project is a pre-implementation-post-implementation evaluation
and will be conducted over three phases. The Promoting Action on Research Implementation in Health Services
(PARiHS) framework will be used to guide implementation. Outcome measurements will be taken 10 weeks
post-implementation of the MAPP. The primary outcomes are: proportion of patients prescribed multimodal
analgesics in accordance with the MAPP; and proportion of patients with moderate to severe pain intensity at
rest. These data will be compared to the pre-implementation analgesic prescribing practices and pain outcome
measures. A secondary outcome, the efficacy of the MAPP, will be measured by comparing pain intensity scores of
patients where the MAPP guidelines were or were not followed.
Discussion: The outcomes of this study have relevance for nursing and medical professionals as well as informing
health service evaluation. In establishing a framework for the sustainable implementation and evaluation of a
standardised approach to post-operative pain management, the findings have implications for clinicians and
patients within multiple surgical contexts.
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A major focus of the worldwide drive to improve the qual-
ity and safety of healthcare is the flexible standardisation of
care processes to ensure patients receive care based on best
available evidence and do not experience unnecessary varia-
tions in quality of care. Pain management after surgery is
known to be a care process where the quality of care is
highly variable. Prevalence studies worldwide identify that
over 80% of hospitalised patients experience pain [1-4].
Pain in the post-operative context is often undertreated
[1,5] and is one of the main post-operative adverse out-
comes [6-8] despite the availability of analgesics and best
evidence regarding their use. In Australia, a review of re-
search concluded that 24% to 40% of hospitalised surgical
patients experienced ‘significant’ pain [9]. Further, a meta-
analysis of published data (1973 to 1999) revealed an overall
incidence of moderate to severe pain for post-surgical pa-
tients calculated at 30% (range: 26% to 33%) and severe
pain at 10% (range: 8% to 13%) [10]. As a consequence of
poor pain management, patients experience unnecessary
suffering and higher incidence of post-operative complica-
tions [11]. More specifically, patients with poorly managed
pain are at risk of developing chronic post-surgical pain
[12,13], experiencing long-lasting psychological distress
[13], and acute neurohormonal changes [13].
Poor use of analgesics has been identified as a prime
reason why patients experience unnecessary pain. Ro-
bust findings indicate that patients receive 50% or less of
the analgesics prescribed [5,6,14,15], do not receive add-
itional analgesics in response to reports of high levels of
pain [14,15], do not benefit from the therapeutic out-
comes of multimodal analgesia [16], and experience side
effects of analgesics such as nausea, vomiting, constipa-
tion, sedation, or bleeding [12,17-19]. In contrast, the ef-
fective use of analgesics can lead to positive outcomes
for both patients and healthcare organisations, such as
reductions in pain [20], opioid use [8,21], nausea and
vomiting [17], hospital length of stay [11,22], and occur-
rences of unplanned hospital re-admissions [23], as well
as improved mobilisation [20,24,25], bowel function
[24], food intake [24], exercise capacity [24], health-
related quality of life [24], and sleep quality [20]. Given
these significant benefits of effective pain management
and the potential consequences of poor analgesic control,
current practices need to be consistent with guidelines de-
veloped from the best available scientific evidence.
Standardisation of care processes to improve quality
and safety of patient care has the potential to transform
the way healthcare is delivered. In 2001, the Institute of
Medicine’s document Crossing the Quality Chasm
highlighted the imperative for patients to ‘…receive
care based on the best available scientific knowledge,’ and
that ‘…care should not vary illogically from clinician to clin-
ician or from place to place’ [26]. The challenge ofstandardising care processes is to achieve the right balance
between maintaining professional autonomy by allowing
clinicians to use clinical judgement and providing clinical
support systems to assist clinicians to select from, and de-
liver, the best treatment options. Clinical situations that
hold the greatest challenge for standardising care are those
that are complex, ill-structured, and have high levels of un-
certainty. Pain management in the post-operative context is
representative of this type of clinical situation. Despite the
dissemination of best-evidence regarding pain and pain
treatment there is not a structured, systematic strategy to
incorporate complex clinical decision-making support
systems into practice to standardise care processes and
improve quality of pain management at point of care.
Multimodal analgesia
To assist health practitioners in the delivery of effect-
ive pain management, professional groups including
the Australian and New Zealand College of Anaesthe-
tists and Faculty of Pain Medicine have published a
thorough review of the scientific evidence supporting acute
pain management [11] and the Procedure Specific Post-
operative Pain Management Group (PROSPECT) have
conducted procedure-specific systematic reviews re-
garding pain management [27]. Best practice recom-
mendations for pharmacological pain management are
for a multimodal approach to treatment, with patients
receiving a mixture of weak and strong analgesics,
administered both locally and systemically. Single anal-
gesics alone, either opioids or non-steroidal anti-
inflammatory drugs (NSAIDS), are not able to provide ef-
fective pain relief for most moderate or severe pain and
are associated with unacceptable side effects [16]. The
combination of drugs with different mechanisms of action
produces synergistic analgesia with lower total doses of in-
dividual analgesics and fewer side effects [17]. Addition-
ally, the timing of the administration of certain adjuvants
(e.g., pre-emptive) has been shown to influence the dose
of analgesics required to manage post-operative pain [28].
Although current guidelines for pharmacological pain
management are comprehensive, they are not presented
in a form that allows healthcare staff to readily implement
recommendations into everyday practice. Consequently,
although multimodal analgesics are often prescribed for
patients in the post-operative setting, evidence from local
contexts suggests that there is substantial variation in pre-
scribing, and analgesics are not used in a multimodal
combination. Rather, they are used in a linear way in keep-
ing with the expected trajectory of recovery after surgery
so that strong analgesics (such as strong opioids) are used
early post-operatively followed by non-opioids. Evidence
from previous research of pain management for cancer
patients highlighted the poor control of patients’ pain des-
pite access to various analgesic treatment options [15].
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ment approaches. In general, analgesic administration is
not guided by specific policy but is instead, left to the
discretion of individual medical or nursing clinicians, often
with less than satisfactory pain management outcomes.
The nature of pharmacological administration decision
making in clinical practice
Nurses play a major role in post-operative pain manage-
ment because they assess pain and administer prescribed
analgesics across the 24-hour continuum of patients’ re-
covery. Decision-making related to analgesic administra-
tion involves a complex interaction between patients’
reports of pain intensity, their behavioural and physical
manifestations of pain, clinician and/or patient attitudes
and beliefs about pain treatment, knowledge of pain
mechanisms and treatments, and clinicians’ previous ex-
perience with patients in pain. The essential principles
of effective pain management are the subjectivity of pain
(the need to accept patients’ interpretation of their pain
intensity and experience), the selection, titration, and ad-
ministration of pain relieving medicines (analgesics) and
instigation of non-pharmacological pain relief strategies.
Applying these principles to individual cases within the
context of the clinical work environment is complex. Clin-
ical realities influence the management of pain in acutely
ill patients. Acute pain management is complex because
of the unpredictable variability of pain (incidence, inten-
sity, and duration), patient characteristics, and pharma-
cological factors [11,29]. This manifests in a variety of
ways in the clinical setting. Patients often experience se-
vere pain past the expected trajectory for a particular sur-
gical procedure. Breakthrough pain can occur prior to the
time for the next dose of analgesic necessitating decisions
regarding dosage and timing of subsequent doses and ad-
equacy of the existing prescription. Adding to the com-
plexity of pain management are organisational factors,
such as local policies, staffing levels and characteristics,
workloads, time of day, availability of doctors and nurses
for consultation, and workplace culture and variability that
all affect day-to-day decision making. There are long-
standing and repeated findings of a poor relationship be-
tween patients’ pain intensity and the amount and type of
analgesic administered by nurses [5,6,15,30-32]. These
findings indicate the need to support nurses’ decision-
making related to the administration of analgesics.
Previous research into the prescription practices re-
lated to analgesics has revealed that a large proportion
of analgesics are prescribed to be administered as PRN
(pro re nata, as required rather than on a fixed schedule)
[15,32] with little guidance to ensure that patients receive
effective multimodal analgesia with minimal side effects
[6,15,32]. There is variation within and between doctors’
and surgeons’ prescriptions for the type and quantity ofanalgesics. This adds to the complexity of day-to-day deci-
sions by nurses about analgesic administration.
Translation of evidence into pain management practices
through the creation and implementation of a clinical
support algorithm
Exploratory work has identified that analgesics are not ad-
ministered according to best practice recommendations
and a significant proportion of patients experience moder-
ate to severe pain while receiving less than 50% of the an-
algesics they have available [6,15,33] or experience
unnecessary side effects associated with analgesics because
they are administered inadequately. There is a demon-
strable need for decision support for the pharmacological
management of pain to facilitate multimodal analgesia.
It is proposed that one such solution, not previously
considered, is the development and implementation of a
Management Algorithm for Post-operative Pain (MAPP)
to support the sustainable translation of evidence-based
pain management practice. The MAPP will be developed
in partnership with clinicians and will address three key
elements of pharmacological pain management: multi-
modal prescribing analgesics; assessment and manage-
ment of breakthrough pain; and prevention of side effects
of analgesics (Table 1). Algorithms are schematic models
of the clinical decision pathway described in a guideline,
presented as step-by-step methods of solving problems
and are increasingly being used in healthcare to support
clinical decision-making and to improve patient care [34].
As graphical representations of clinical practice guidelines,
algorithms serve to promote the standardisation of clinical
processes while allowing for the clinical variation that oc-
curs in real-world contexts. In the area of pain manage-
ment, algorithms have been used sparsely, e.g., to assist
nurses with pain management in post-anaesthetic care
units [35], for post-operative intramuscular analgesia
[36,37], and for pain management following specific pro-
cedures (e.g., hematopoietic cell transplants [38]) and con-
ditions (e.g., persistent shoulder pain [39], spinal cord
injury [40]). None of these algorithms, however, have been
designed to address the complexity of pharmacological
pain management in the post-operative context where
there is high variability in prescribing practices, staff skill
mix, patient characteristics and risk, and a wide array of
available classes of analgesics.
Although post-operative pain is poorly managed gene-
rally, the study will be focused in orthopaedic surgery be-
cause this surgery is common and is associated with high
levels of pain that, if not well managed, interferes with re-
habilitation, recovery, and long term benefits of surgery.
Prolonged moderate to severe pain can lead to chronic
pain in a proportion of patients [41-43]. The MAPP will
be developed for patients undergoing total hip or knee re-
placement surgery because of the emerging evidence that
Table 1 Key elements of the MAPP
Element Principles
Multimodal analgesic
prescribing
Reduced variability between prescribers
Multimodal opioid sparing regime (41,42)
• Strong opioid
• Weak opioid
• NSAID*
• Paracetamol
Analgesics prescribed on a fixed
schedule
Assessment of pain Use of 11-point numerical rating scale
for pain intensity
Pain intensity rating ≥4 (pain or rest)
indicative of breakthrough pain
Frequency of pain intensity assessment
• Two-hourly when awake
• Four-hourly when asleep
• Reassessment of pain intensity within
30 minutes of treatment for breakthrough
Management of breakthrough
pain and prevention/control
of analgesic side effects
Availability of analgesics prescribed as PRN
Algorithmic support for treatment
decisions
Availability of pre-emptive treatments
for nausea and constipation
Escalation plan if breakthrough
pain persists
Review of causation and plan of
treatment to prevent recurrence
*non-steroidal anti-inflammatory drugs (NSAID).
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[44-47]. The number of hip replacement surgeries per-
formed in Australia since 2003 has increased by 39.2% and
knee replacement surgeries have increased by 63.5% [48].
Aims
The project will be conducted in three incremental
phases to achieve the aims of the project:
1. Develop a post-operative, pharmacological pain
management algorithm based on best available evi-
dence in collaboration with a multidisciplinary panel
to effectively manage pain in the post-operative
orthopaedic environment (phase one);
2. Implement the pain management algorithm using
an evidence-based, multidimensional framework
for the successful implementation of change in
practice (phase two);
3. Evaluate the impact of the algorithm on patients’
pain experience and pharmacological pain
management practices across multiple sites using a
pre- and post-implementation designed study (phase
three).More specifically the objectives are to:
1. Examine and calculate the proportion of post-
operative analgesic prescriptions that comply with
the MAPP;
2. Determine the proportion of patients who
experience moderate to severe pain after TKR and
THR, pre- and post-implementation of the MAPP;
3. Explore the efficacy of MAPP prescribing and
administration by comparing the pain intensity ratings
of patients whose analgesic prescriptions comply with
MAPP recommendations with the ratings of patients
whose prescriptions do not comply;
4. Examine medical records for documented rationale
explaining variation to MAPP prescribing
recommendations.Methods
Design
There are two fundamental components of this research:
the systematic development of the management algo-
rithm for post-operative pain (MAPP) that is ecologically
valid and based on best available evidence (phase one),
and implementation of the MAPP into clinical practice
in a way that ensures uptake and integration (phase
two), and establishes a framework for measuring sustain-
ability. Improving pain management is a multidisciplin-
ary endeavour and is dependent on strong collaborative
relationships between disciplines, administrators and pa-
tients themselves. There is potential for widespread up-
take of the pain management algorithm however it is
necessary, in the first instance to quantify the benefits in
terms of quality improvement and develop a model for
widespread implementation. The three-phase approach
to this project will enable consultation and cooperation
between disciplines and with patients (phase one), and
identify barriers and enablers for successful implementa-
tion (phase two).
The design of phase three is a pre- and post-
implementation study to evaluate the uptake and out-
comes of the MAPP in three sites.Setting
Phases one and two will be conducted in the ortho-
paedic units of a large private hospital in Melbourne,
Australia (coordinating site) and will be rolled-out
(phase three) in two additional orthopaedic sites in Mel-
bourne, one private hospital, and one public hospital to
test transferability and uptake. Three hospitals will par-
ticipate in phase three, two private sector and one public
sector. More than one-half of all hip replacement surge-
ries are performed in the private sector (59.3% in 2011)
and more than two thirds of all knee replacement
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2011) [48].
Phase one: development of the MAPP
The purpose of phase one is to develop the MAPP, de-
termine the implementation strategy in the coordinating
site, and plan the roll out to the two other participating
sites. The first step is to identify the local context issues
related to pain management and determine the scope of
the guidelines. This will be achieved through a series of
point prevalence surveys in the orthopaedic units to de-
termine peri-operative, analgesic prescribing practices of
anaesthetists and surgeons, and post-operative pain out-
comes of patients. The second step is to convene an ex-
pert multidisciplinary panel and reach a consensus on
the MAPP analgesic guidelines that is both context and
procedure (total hip and total knee replacement)
specific.
It is envisaged that the evidence from the point preva-
lence surveys conducted will assist participating anaesthe-
tists and surgeons to reach consensus about standardising
analgesic prescriptions for peri-operative orthopaedic pa-
tients within the local context.
Prevalence surveys of pain management practices and
pain outcomes
Sequential point prevalence surveys will provide essen-
tial baseline and outcome data throughout the three
phases of this project. The point prevalence surveys will
be conducted on the orthopaedic wards of participating
hospitals. Data will be collected by research personnel
who are also nurses and therefore familiar with pain as-
sessment and analgesic prescribing.
Participants
The study participants are all anaesthetists and surgeons
who prescribe perioperative analgesics for patients under-
going THR and TKR surgery, nurses employed on the
orthopaedic units who administer analgesics, and post-
operative patients present on the wards at the time of the
point prevalence surveys.
Inclusion criteria (patients)
1. Aged 18 years and over.
2. Have undergone a total hip or total knee
replacement in the previous 7 days (i.e., are Day 0 –
7 post-surgery).
3. Are present on the orthopaedic ward at the time of
the point prevalence survey(s).
Procedure
Data collection for the surveys will include patient inter-
views and medical record audit. Prevalence of pain, painintensity, and the impact of pain on activities of daily liv-
ing will be collected via brief interviews with patients
(approximately five minutes) about their pain experience
during the previous 24 hours. In order to capture the
prescribing practices of all anaesthetists and surgeons,
and the pain outcomes of patients across the recovery
trajectory (Day 0 – 7), five prevalence surveys will be
conducted over five weeks. In week one, the surveys will
be conducted on Monday, in week two on Tuesday, and
so on. In the coordinating centre, there are expected to
be approximately 60 eligible patients available per day.
Patient interviews
1. Patients’ demographic characteristics and relevant
medical history.
2. Pain intensity rating of current pain (pain at rest)
and worst and average pain in the previous 24 hours
will be measured on an 11-point numerical rating
scale (NRS) where 0 denotes no pain and 10 denotes
worst pain possible) [5].
3. Interference with activities of daily living and patient
satisfaction will be measured using sections of the
revised American Pain Society Patient Outcomes
Questionnaire (APS-POQ-R) [49,50], a well-
validated instrument that has been used in a number
of studies [5].
Medical record audit
Pharmacological pain treatment survey
This survey, used previously by the investigators, elicits pa-
tient information relating to height, weight and body mass
index, current surgery and sequelae, as well as the type and
quantity of analgesics prescribed prior to admission, the
type of anaesthetic techniques used intra-operatively and
the type and quantity of analgesic and symptom manage-
ment medications prescribed and administered in the 24-
hour period prior to the patient interview.
Data analysis
The purpose of the point prevalence survey in phase one
is to inform the development of the MAPP by providing
rich descriptive data of current analgesic prescribing and
administration practices to allow comparisons with guide-
lines based on best available evidence. Patients’ pain out-
comes will provide evidence for the need to change existing
practices and identify where the main gaps in practice are,
for example whether the gaps relate to prescribing of
analgesics or treatment of breakthrough pain. In
addition, the survey data will be the pre-implementation
data for evaluating the success of the implementation of
MAPP in phase two.
Frequencies and other descriptive statistics will be
used to describe the sample, pain intensity ratings and
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ratings greater than 3 and 7 or less, will be categorised
as moderate pain and ratings greater than or equal to 8
will be categorised as severe pain. Analgesic prescrip-
tions will be described in terms of drug group (strong
opioid, weak opioid, non-steroidal anti-inflammatory
drug (NSAID), or paracetamol) and available doses over
24 hours. The amount and type of analgesics patients re-
ceive will be analysed as a ratio of the total amount pre-
scribed for the 24-hour period prior to the survey. In
addition, The Pain Management Index will be calculated
for each patient. Scores are calculated based on the rela-
tionship between worse pain intensity scores and po-
tency of analgesic administered. Evidence of the validity
of this index has been demonstrated by Ward et al. in
the cancer pain management context [51].
Expert multidisciplinary advisory panel
Following the point prevalence surveys, an expert advis-
ory panel will be convened with multidisciplinary and
consumer representation to advise on the development,
dissemination, and implementation of the guidelines.
We will use the pre-intervention survey results to high-
light current practice and engage clinicians for improv-
ing post-operative pain management and consequently
improving pain outcomes for patients. The panel will in-
clude the project team with the addition of representa-
tives from the craft groups of surgeons, anaesthetists,
pharmacists, nurses and patients. A representative from
health information services will advise on the integration
of the algorithm into permanent medical records. Key
members of the panel (surgeons, anaesthetists) will also
liaise with their colleagues to promote standardisation of
prescribing practices.
The brief for the multidisciplinary panel at the coordin-
ating site will be to assist the development of a MAPP
based on the best scientific evidence and focused on stan-
dardising analgesic prescription and able to be applied by
registered nurses caring for post-operative orthopaedic pa-
tients who have undergone total knee replacement (TKR)
or total hip replacement (THR) surgery.
To develop the pharmacological pain management al-
gorithm, we will follow the general steps of guideline de-
velopment published by the National Health and
Medical Research Council [52]. The panel at the coord-
inating site will evaluate best available evidence, manage-
ment of risk, local practice issues that may impact upon
uptake and utilisation of the algorithm, transferability of
the algorithm to other orthopaedic post-operative en-
vironments and evaluation of the outcomes post-
implementation. The panel will also consider the natural
history of the conditions being treated, the possible out-
comes of MAPP, the benefits versus the risks of each
intervention, and the clinical supports required tofacilitate safe uptake of the intervention. The panel will
advise on the dissemination and implementation of the
MAPP at the coordinating site and also consider the
specific modifications for its application at the two roll
out sites.
A Clinical Nurse Consultant (CNC) role will be also
be created. The CNC will act as the project facilitator
in the development, implementation and evaluation of
the pharmacological algorithm. The CNC will be based
at the coordinating institution and have significant ex-
perience in post-surgical nursing and pain manage-
ment and also be able to play a significant role in the
expert panel. The CNC will also be required to liaise
with the interdisciplinary panel members and ortho-
paedic surgeons and anaesthetists, and be involved in
the development of the algorithm.
Consideration will be given to presenting the algo-
rithm in a form that facilitates comprehension by clini-
cians and is flexible to suit information needs and
knowledge levels of different audiences (e.g., consumers,
specialist and non-specialist health professionals) and
one that complies with national and local criteria regard-
ing the prescription of medications.
Phase two: development and pilot of the implementation
framework for the MAPP
The aim of phase two is to formulate the dissemination,
implementation, revision, and evaluation strategies. This
phase of implementation of the MAPP will occur in the
coordinating site to identify barriers to uptake and ad-
herence, and to refine the implementation strategy for
the rollout to the other two sites.
Implementation framework
The Promoting Action on Research Implementation in
Health Services (PARiHS) framework [53-55] will be used
to guide the implementation of the clinical algorithm into
practice. Research on the diffusion or adoption of innova-
tions suggests that successful change implementation is a
function of the relationship between evidence, context,
and facilitation [54]. The PARiHS framework has been
used successfully in an action research study on improving
post-operative pain management [56]. In partnership with
key clinicians and clinician groups and other stakeholders
we intend to implement and evaluate the pain manage-
ment algorithm using this framework. For implementation
to be successful, there needs to be clarity about the nature
of the evidence being used, the quality of the context, and
the type of facilitation needed to ensure a successful
change process. These steps are outlined in detail below.
Evidence
According to the PARiHS framework [53-55], evidence
comes from four sources: research, clinical experience,
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MAPP study, research evidence will be derived predom-
inantly from the acute pain management guidelines [11]
and consensus from the members of the expert panel;
patient experience will be informed by patient represen-
tation on the panel, and local data/information will
come from the prevalence surveys and the resources of
the panellists who are in clinical positions.
Context
Context, according to the PARiHS framework, is made
up of three factors: culture, leadership, and evaluation.
Brown and McCormack [56] contend that learning cul-
tures, transformational leadership, and effective evalu-
ation mechanisms promote the implementation of
research into practice. Context is a core component of
the implementation design of the MAPP. The appointed
Clinical Nurse Consultant (coordinating site) and Clin-
ical Nurse Specialists at the roll out sites will oversee the
pilot implementation framework. Ongoing evaluation
mechanisms will provide feedback to promote the devel-
opment of a model for the successful implementation of
MAPP into practice.
Facilitation
Facilitation refers to the process of enabling or making
easier the implementation of change and is achieved by
individuals carrying out specific roles within organisa-
tions to facilitate change [42]. We will use strategies that
have been consistently effective in producing evidence-
based practice changes [52,57], including interactive
educational meetings (e.g., active participation in work-
shops, small-group discussion, problem-based learning),
educational outreach visits (e.g., trained personnel pro-
viding face-to-face visits to clinicians), and other re-
minders (e.g., visual resources and reminders about
using the algorithm). Research personnel in the project
team will oversee the education component and develop
an on-line education module for the multi-site roll out.
Prevalence survey of pain management practices and
pain outcomes: pilot implementation
To evaluate the uptake and efficacy of the algorithm, an-
other survey of pain management practices and pain
outcomes will be performed 10 weeks after the im-
plementation of the MAPP in the orthopaedic units.
The results will be compared to the pre-implementation
survey. The same procedure will be used to collect these
data.
The extent to which clinicians have adopted the pain
management algorithm in terms of prescribing and
multimodal medication administration, will be deter-
mined through the medical record audit. This method
will be evaluated and an ongoing evaluation strategy forcontinuing quality assurance and sustainability will be
established.
Primary outcomes
The primary outcome measures to determine successful
implementation are the proportion of patients who have
multimodal analgesic prescriptions in accordance with
the MAPP, 10 weeks after implementation, to determine
the extent to which clinicians have adopted the prescrib-
ing guidelines, and the proportion of patients with mod-
erate to severe pain intensity scores to determine
whether the treatment of breakthrough pain is in ac-
cordance with the MAPP.
Sample size
The sample size calculations are based on pilot data of
pain prevalence and pain management practices con-
ducted by Botti et al. The minimum sample size required
to detect a 20% reduction in the proportion of THR pa-
tients with moderate to severe pain intensity (current
prevalence 33%, reduce to 13%) at rest is 78 and for TKR
patients (current prevalence 53%, reduce to 33%) is 109.
This number of participants would provide the power to
show an advantage for the post-intervention group with
85% power at the 5% significance level. Therefore a mini-
mum of 187 patients will be recruited in phase one and
187 in phase two (total n =374).
Data analyses
Data gained from the post-implementation surveys will
be compared to the pre-implementation survey data in
order to determine the effectiveness of the implementa-
tion strategies for introducing the MAPP into practice.
T-tests and chi-square tests will be used to compare
baseline characteristics between the pre- and post-
implementation patient groups. Non-parametric statis-
tical analyses will be used to detect significant differ-
ences in the proportions of patients with analgesic
prescriptions in accordance with the MAPP, and patients
with moderate to severe pain. Tests will be two-tailed
with statistical significance set at an alpha level of 0.05.
The analyses will be undertaken using STATA©.
Phase three: external application of the MAPP and
implementation framework
The aim of phase three is to implement and evaluate the
transferability and uptake of the MAPP and establish a
framework for measuring sustainability of the MAPP in
multiple sites beyond the development site. This will be
an important aspect of ensuring that the MAPP fits the
different contexts of public and private healthcare and is
transferable with modifications for the local contexts.
There will be a 10-week, pre-implementation stage and
a 10-week, post-implementation stage at each of the two
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politan Melbourne). Point prevalence surveys and multi-
disciplinary panel methodologies used in phase one and
the implementation and evaluation methodologies applied
in phase two will be repeated at each rollout site.
Prevalence surveys pre- and post-implementation of
the MAPP
The point prevalence surveys will be used to determine
the quality of pain management practices at each site
pre-implementation, in order to identify any site specific
issues to be considered, allow modification of the im-
plementation framework, and provide data for the pre-
and post-implementation comparisons. Data collection
methods including patient eligibility, survey and med-
ical record audit will be the same as those described in
phases one and two.
Multidisciplinary panel at rollout sites to facilitate transfer
of MAPP according to local contexts
A site specific multidisciplinary panel will be convened
after the pre-intervention point prevalence surveys have
been completed for the purpose of reviewing the find-
ings and assessing analgesic prescribing and administra-
tion practices to determine whether there are local
contextual factors that require the MAPP to be modi-
fied. The panel will oversee and advise on the contextual
modification of the algorithm based on the best scien-
tific evidence. In doing so the panel will also consider
the clinical supports required to facilitate safe uptake of
the intervention in each site. The CNC at the coordinating
site will also work closely with the Clinical Nurse Special-
ists on the orthopaedic wards of the two rollout sites to fa-
cilitate implementation and evaluation of the MAPP.
Implementation, revision, and evaluation of the MAPP at
each rollout site
The implementation, revision and evaluation method-
ologies described in phase two in the coordinating site
will be used in the rollout sites.
Primary outcomes
The primary outcome measures identified in phase two
will be applied again in phase 3 to establish the uptake
of the MAPP by examining the proportion of patients
whose analgesic prescriptions comply with the MAPP
and the proportion of patients with moderate to severe
pain at rest.
Secondary outcome
The secondary outcome measure will be the efficacy of
MAPP prescribing and administration by comparing the
pain intensity ratings (current, worst, and average pain)
of patients whose analgesic prescriptions comply withMAPP recommendations with the ratings of patients
whose prescriptions do not comply.
In addition, process evaluation will include an examin-
ation of all medical records for any documented rationale
by clinicians explaining a variation to MAPP prescribing
recommendations such as allergies or contraindications.
The number and nature of site-specific changes made
in order to implement the MAPP at each site will be re-
corded and analysed in order to inform the transferabil-
ity of the MAPP across health services.
Sample size
The phase three study is powered to detect changes in
point prevalence surveys before and after MAPP imple-
mentation for the two primary outcomes. A type I error
of 0.05, power of 0.85 and intra-cluster correlation effect
of 0.2 to account for hospital clustering effect have been
considered. Based on these assumptions and a preva-
lence of moderate to severe pain at rest of 33.8% for
THR patients and 53.1% for TKR patients, 94 THR pa-
tients and 131 TKR patients in each prevalence survey is
needed to detect a 20% reduction in the proportion of pa-
tients with moderate to severe pain at rest (Rest pain >3/
10). With a total 450 patients and an estimated 15.5%
compliance with multimodal analgesic prescribing (ac-
cording to pilot data at the coordinating site), there is 0.85
power to detect a minimum of 13% improvement in pre-
scribing adherence.
Data analysis
Again pre- and post-implementation data will be com-
pared to determine the uptake of the MAPP by doctors
and nurses. T-tests and chi-square tests will be used to
compare baseline characteristics between the pre- and
post-implementation patient groups. Non-parametric
statistical analyses will be used to detect significant dif-
ferences in the proportions of patients with analgesic
prescriptions in accordance with the MAPP, and patients
with moderate to severe pain. Due to intra correlation of
hospitals adjusting for clustering effects is necessary. Ap-
propriate generalised linear mixed models (GLMMs) for
binary outcomes with logistic link will be used to evalu-
ate the relationships between the main outcomes and
the MAPP while adjusting for any important risk factors
or covariates. Tests will be two-tailed with statistical sig-
nificance set at an alpha level of 0.05. The analyses will
be undertaken using STATA©.
A secondary outcome to be analysed is the efficacy of
the MAPP in reducing pain intensity ratings by compar-
ing pain intensity ratings of patients where the MAPP
guidelines are followed with those where the guidelines
are not followed. Given that we are expecting to improve
prescribing adherence from 15.5% to at least 28% (but it
is likely to be much higher) we estimate we would have
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compliance group. The minimum sample size required
to measure a difference in mean pain intensity prior to
and following implementation is 86. Data from previous
research by Botti et al. were used to calculate power to
show an advantage of at least 15 units (1.5 on VAS) for
the post-intervention group with 80% power at the 5%
significance level. Change differences of two points in
cancer populations [58] and 3 points in surgical popula-
tions [59] have been shown to have clinical significance
on a 0-10 Visual Analogue Scale.
Ethics approval
All phases of this study have been approved by the Hu-
man Research and Ethics Committees at the coordinat-
ing hospital and two supporting hospitals. The project
has also been reviewed and approved by the Deakin Uni-
versity Human Research Ethics Committee.
Discussion and conclusions
One of the key priority goals of research in the area of
preventative healthcare is to reduce the risk of adverse
outcomes. Ineffective pain management has significant
moral, clinical, and financial implications for health. The
impact of poor pain management is substantial in both
human and economic terms. The use of medicines is the
most common method of healthcare treatment [60].
There is growing recognition that unrelieved pain can
adversely affect outcomes from surgery and may lead to
persistent (chronic), long term pain, with associated eco-
nomic and societal costs [11]. This work directly addresses
the need for evidence-based preventative interventions
that reduce the incidence and severity of adverse out-
comes associated with ineffective pain management.
The drive for quality improvement through evidence-
based healthcare is a dominant theme in practice, man-
agement and education in health services worldwide.
There is recognition of the need for system change to
support the delivery of safe, high-quality care. The algo-
rithm will be developed according to previously described
recommendations for post-operative pain management
for patients undergoing total hip or total knee replace-
ment surgery. It is not enough, however, to introduce tools
and strategies with which to improve quality of care with-
out acknowledging the complexities of change processes,
the need to engage staff, and the imperative to make any
practice changes sustainable in the long term [61]. Trad-
itionally, improvements in the processes of healthcare de-
livery in acute care occur in uncontrolled environments
without the ability to adequately evaluate the outcomes.
This has sometimes resulted in unintended or negative
consequences occurring as a result of a change in practice.
This project will evaluate the implementation of a
process to improve the quality of pain managementthrough standardising evidence-based care processes
thereby assisting complex decision making by clinicians
at the point-of-care. The project will also identify the
key components of successful adoption across sites and
healthcare sectors.
The proposed intervention directly addresses the need
for evidence-based interventions that reduce the inci-
dence of adverse events and improves the quality of care
delivery. Specifically, this project addresses the high
prevalence of moderate and severe pain experienced by
post-surgery orthopaedic patients. Developing improved
processes for the effective prescription and administra-
tion of post-operative analgesics applies not only to
orthopaedic surgery but to many other surgical contexts
and thus will impact on a large number of patients in
Australia and internationally.
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